Oncology & Cancer

Thirty percent fewer prostate cancer deaths with PSA screening

PSA screening cuts deaths from prostate cancer by some 30 percent. This research was based on data of 20,000 men monitored for more than two decades. The men's initially measured PSA levels proved highly significant as a ...

Oncology & Cancer

Early PSA testing could help predict prostate cancer among black men

Prostate cancer is the second most common cancer in American men. But black men bear a disproportionate burden of its effects. It's more common—and more than twice as deadly—among black men compared to their white counterparts. ...

Oncology & Cancer

How microchips could help detect prostate cancer

Professor of Electronic Engineering Andrew Flewitt is working with researchers at the Cancer Research UK (CRUK) Cambridge Centre on a more accurate PSA blood test to detect prostate cancer.

Oncology & Cancer

Prostate cancer diagnosis later for Kiwi men

New Zealand men are being diagnosed with prostate cancer later in life at a higher prostate-specific antigen (PSA) level and higher disease grade compared to men in the United States according to University of Auckland research.

page 10 from 33